<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We explore three questions concerning arterial hyperoxygenation and focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="?"><plain>(1) Does greater benefit accrue with higher levels of arterial hyperoxemia </plain></SENT>
<SENT sid="2" pm="?"><plain>(2) Is the net effect of continuous (intraischemic plus postischemic) oxygen therapy toxic, or beneficial to <z:e sem="disease" ids="C0740392" disease_type="Disease or Syndrome" abbrv="">middle cerebral artery infarction</z:e> </plain></SENT>
<SENT sid="3" pm="?"><plain>(3) In view of free radical theories of reperfusion injury, does <z:mp ids='MP_0002319'>hyperoxia</z:mp> isolated to the reperfusion period damage tissue </plain></SENT>
<SENT sid="4" pm="."><plain>Rats subjected to transient, focal, normothermic, normoglycemic <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> were assessed at 2 weeks' survival </plain></SENT>
<SENT sid="5" pm="."><plain>Arterial hyperoxygenation from 98.9 +/- 4.0 to 312.2 +/- 48.4mm Hg during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> improved (p &lt; 0.05) neurological function, as did isolated reperfusion hyperoxemia, but treatment with continuous hyperoxemia both during and after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> yielded greatest benefit (p &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Cortical <z:mpath ids='MPATH_124'>infarcts</z:mpath> constituted 6.5 +/- 1.8% of the hemisphere at normoxia, but 2.3 +/- 0.9% at hyperoxic levels (p &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain><z:mp ids='MP_0002319'>Hyperoxia</z:mp> isolated to the reperfusion period also reduced cortical <z:mp ids='MP_0001651'>necrosis</z:mp>, from 6.5% to 2.7 +/- 1.2% </plain></SENT>
<SENT sid="8" pm="."><plain>However, continuous intraischemic and reperfusion hyperoxemia led to only 0.2 +/- 0.1% cortical <z:mp ids='MP_0001651'>necrosis</z:mp> (p = 0.0005) </plain></SENT>
<SENT sid="9" pm="."><plain>Increasing the degree of hyperoxemia did not augment the benefit </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that (1) eubaric hyperoxemia improves neurological and neuropathological outcome, (2) continuous oxygen therapy offers the greatest benefit, and (3) reperfusion hyperoxemia is beneficial </plain></SENT>
<SENT sid="11" pm="."><plain>The findings should allay clinical concerns regarding oxygen-induced reperfusion injury, and, by obviating hyperbaric chambers, encourage clinical trials studying arterial hyperoxemia in treating <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>